Found 5 results

Name Type of Offering Accepted Date
Auron Therapeutics, Inc. See All Filings
D/A 2023-10-20 09:07:13
Amount To Be Raised $48,249,997
Associated Brokers / Dealers N/A
CIK Number 0001746139
Filed Document 0001746139-23-000002
Exclusions or Exemptions 506b
Accepted Date 2023-10-20 09:07:13
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Auron Therapeutics, Inc. See All Filings
D 2024-12-31 09:50:27
Amount To Be Raised $41,789,180
Associated Brokers / Dealers N/A
CIK Number 0001746139
Filed Document 0001746139-24-000003
Exclusions or Exemptions 506b
Accepted Date 2024-12-31 09:50:27
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Auron Therapeutics, Inc. See All Filings
D 2018-07-25 09:14:15
Amount To Be Raised $1,500,000
Associated Brokers / Dealers N/A
CIK Number 0001746139
Filed Document 0001746139-18-000001
Exclusions or Exemptions 506b
Accepted Date 2018-07-25 09:14:15
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Debt
Auron Therapeutics, Inc. See All Filings
D 2020-12-16 13:08:44
Amount To Be Raised $15,441,157
Associated Brokers / Dealers N/A
CIK Number 0001746139
Filed Document 0001746139-20-000001
Exclusions or Exemptions 506b
Accepted Date 2020-12-16 13:08:44
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Auron Therapeutics, Inc. See All Filings
D 2022-07-28 10:07:39
Amount To Be Raised $48,249,997
Associated Brokers / Dealers N/A
CIK Number 0001746139
Filed Document 0001746139-22-000001
Exclusions or Exemptions 506b
Accepted Date 2022-07-28 10:07:39
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity